This Article Full Text Full Text (PDF) All Versions of this Article: 38/6/1988    most recent STROKEAHA.106.473918v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peña, C. Articles by Melkerson, M. Search for Related Content PubMed PubMed Citation Articles by Peña, C. Articles by Melkerson, M. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Acute Cerebral Infarction Other Stroke Treatment - Medical Other Stroke Treatment - Surgical Related Article

(Stroke. 2007;38:1988.)
© 2007 American Heart Association, Inc.

Emerging Therapies

An Example of US Food and Drug Administration Device Regulation

Medical Devices Indicated for Use in Acute Ischemic Stroke

Carlos Peña, PhD; Khan Li, MD; Richard Felten, MS; Neil Ogden, MS Mark Melkerson, MS

From the Division of General, Restorative, and Neurological Devices, Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Md.

Correspondence to Carlos Peña, PhD, Office of Science and Health Coordination, FDA/HHS, 5600 Fishers Lane, HF-33 Rm 14B08, Rockville, MD 20857. E-mail carlos.pena{at}fda.hhs.gov

Marc Fisher MD Kennedy Lees MD Section Editors:

The Food and Drug Administration has established requirements for protecting the public health by assuring the safety and effectiveness of a variety of medical products including drugs, devices, and biological products, and for promoting public health by expediting the approval of treatments that are safe and effective. The Center for Devices and Radiological Health is the center within the agency that is responsible for pre- and postmarket regulation of medical devices. In this article, we review current regulation of medical devices, research and development programs, pre- and postmarket perspectives, and future considerations of medical devices, particularly as they relate to devices targeting acute ischemic stroke as an example of the process. We also review the Center for Devices and Radiological Health’s historical perspective of acute ischemic stroke trials and clinical trial design considerations used in prior studies that have led to US market clearance as they are related to currently marketed devices indicated for acute ischemic stroke.

Key Words: acute stroke • stroke • treatment

Related Article:

Regulatory Device Approval for Stroke: Fair and Balanced?

Larry B. Goldstein
Stroke 2007 38: 1737-1738. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				L. B. Goldstein Regulatory Device Approval for Stroke: Fair and Balanced? Stroke, June 1, 2007; 38(6): 1737 - 1738. [Full Text] [PDF]